Overall rank by patents
#3,247
Across all tracked assignees
USPTO PatentsView assignee record - 115 granted patents across 13 technology areas, active 2020–2025. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: G07F (COIN-FREED OR LIKE APPARATUS).
The verdict
Adrenalineip holds 115 US patents across 13 technology areas, rank #3,247 of 50,000 tracked assignees.
Adrenalineip has been granted 115 US utility patents between 2020 and 2025, placing Adrenalineip at rank #3,247 across all assignees tracked by PlainPatent. This portfolio spans 13 distinct Cooperative Patent Classification (CPC) subclasses, averaging 11.1 claims per patent with primary concentration in G07F (COIN-FREED OR LIKE APPARATUS). As a US Corporation, Adrenalineip is one of the more focused assignees in the PatentsView dataset. By volume, Adrenalineip sits between Wiwynn Corporation (116 patents, rank #3,243) and Coinbase, Inc. (115 patents, rank #3,251) - the closest US assignees by grant volume. The composite Innovation Score of 55.9/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.
Filing cadence tells the strategic story. Historical data spans 2020 through 2025, with 115 total grants over that period. Velocity comparisons require five years of historical filings to calibrate. The US Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.
Claim depth and technology breadth together indicate competitive posture. Adrenalineip's 11.1 average claims per patent suggests focused, narrowly drawn claims typical of single-invention filings, while concentration in 13 subclasses points to a focused technical program. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark Adrenalineip against peers pursuing similar technology classes.
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
Wiwynn Corporation
116 patents
ABUS August Bremicker Söhne KG
115 patents
ALEDIA
115 patents
Achates Power, Inc.
115 patents
CATALYST LIFESTYLE LIMITED
115 patents
Cognitive Scale, Inc.
115 patents
Coherent Logix, Incorporated
115 patents
Coinbase, Inc.
115 patents
AdrenalineIP
115 patents
What this shows Adrenalineip holds 115 patents at rank #3,247, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
By rank, the assignees closest to #3,247 in granted patent volume.
Other assignees with the most granted patents in Adrenalineip's primary technology class.
Adrenalineip's Innovation Score vs. every tracked assignee
Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)
56 Top 7% higher than 93% of 50,000 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Teal-shaded recent years (2020–present) versus the 2020–2019 baseline. Full figures in the table below.
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2020 | 1 | 0.9% |
| 2021 | 12 | 10.4% |
| 2022 | 26 | 22.6% |
| 2023 | 25 | 21.7% |
| 2024 | 35 | 30.4% |
| 2025 | 16 | 13.9% |
Top 13 of 13 technology areas
Overall rank by patents
#3,247
Across all tracked assignees
55.9 out of 100
How to use this portfolio
Adrenalineip's 115 grants land it in the top 7% by Innovation Score, but volume alone doesn't tell you where the strength sits.
Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.